S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
S&P 500   3,320.79 (-0.27%)
DOW   29,196.04 (-0.52%)
QQQ   223.28 (-0.04%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in
(Ad)
This little-known smart chip is crucial for the new 5G networks. And with 1 billion 5G devices coming online within 4 years...the market is estimated to be worth $12.3 TRILLION! This just-released special report reveals urgent details.

NYSE:LH - Laboratory Corp. of America Stock Price, Forecast & News

$179.63
+2.63 (+1.49 %)
(As of 01/21/2020 04:00 PM ET)
Today's Range
$176.55
Now: $179.63
$179.96
50-Day Range
$166.59
MA: $171.19
$180.39
52-Week Range
$134.79
Now: $179.63
$181.49
Volume647,600 shs
Average Volume784,869 shs
Market Capitalization$17.44 billion
P/E Ratio23.64
Dividend YieldN/A
Beta1.02
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.33 billion
Cash Flow$16.93 per share
Book Value$69.09 per share

Profitability

Net Income$883.70 million

Miscellaneous

Employees61,000
Market Cap$17.44 billion
Next Earnings Date2/13/2020 (Confirmed)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

Join a small community of investors looking for the next big winner. Every Sunday reveals 3 compelling stocks that should be on your radar for the week ahead. Sign up here to see what stocks have made it to our watchlist this week.

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) released its quarterly earnings data on Thursday, October, 24th. The medical research company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.85 by $0.05. The medical research company had revenue of $2.93 billion for the quarter, compared to analyst estimates of $2.91 billion. Laboratory Corp. of America had a return on equity of 15.33% and a net margin of 6.63%. The firm's revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $2.74 earnings per share. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Laboratory Corp. of America.

How can I listen to Laboratory Corp. of America's earnings call?

Laboratory Corp. of America will be holding an earnings conference call on Thursday, February 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America issued an update on its FY19 earnings guidance on Thursday, October, 24th. The company provided earnings per share guidance of $11.20-$11.30 for the period, compared to the Thomson Reuters consensus estimate of $11.27. The company issued revenue guidance of $11.5-$11.56 billion, compared to the consensus revenue estimate of $11.48 billion.

What price target have analysts set for LH?

13 brokers have issued 12-month target prices for Laboratory Corp. of America's stock. Their forecasts range from $164.00 to $220.00. On average, they expect Laboratory Corp. of America's share price to reach $189.30 in the next year. This suggests a possible upside of 5.4% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 2 sell ratings, 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News articles about LH stock have been trending somewhat positive on Tuesday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a news impact score of 2.0 on InfoTrie's scale. They also gave news stories about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Laboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a decline in short interest in December. As of December 13th, there was short interest totalling 1,490,000 shares, a decline of 6.3% from the November 28th total of 1,590,000 shares. Based on an average trading volume of 568,200 shares, the days-to-cover ratio is currently 2.6 days. Currently, 1.5% of the company's stock are short sold. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Amgen (AMGN), Micron Technology (MU), NVIDIA (NVDA), Endologix (ELGX), Allergan (AGN), Gilead Sciences (GILD), Chipotle Mexican Grill (CMG) and AT&T (T).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.54%), Global Thematic Partners LLC (0.31%), Wedge Capital Management L L P NC (0.25%), PGGM Investments (0.25%), Hahn Capital Management LLC (0.18%) and Hexavest Inc. (0.16%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Calamos Advisors LLC, Zurcher Kantonalbank Zurich Cantonalbank , Hahn Capital Management LLC, Nisa Investment Advisors LLC, Triad Investment Management, First National Bank of Omaha and Capital Investment Advisors LLC. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Assenagon Asset Management S.A., Wedge Capital Management L L P NC, Birch Hill Investment Advisors LLC, Global Thematic Partners LLC, DNB Asset Management AS, Boston Trust Walden Corp and Forte Capital LLC ADV. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $179.63.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $17.44 billion and generates $11.33 billion in revenue each year. The medical research company earns $883.70 million in net income (profit) each year or $11.02 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  488 (Vote Outperform)
Underperform Votes:  536 (Vote Underperform)
Total Votes:  1,024
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel